JP2006505290A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006505290A5 JP2006505290A5 JP2005506685A JP2005506685A JP2006505290A5 JP 2006505290 A5 JP2006505290 A5 JP 2006505290A5 JP 2005506685 A JP2005506685 A JP 2005506685A JP 2005506685 A JP2005506685 A JP 2005506685A JP 2006505290 A5 JP2006505290 A5 JP 2006505290A5
- Authority
- JP
- Japan
- Prior art keywords
- peroxiredoxin
- fragment
- pharmaceutical composition
- vihum
- prx
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000012634 fragment Substances 0.000 claims 16
- 102000007456 Peroxiredoxin Human genes 0.000 claims 15
- 108030002458 peroxiredoxin Proteins 0.000 claims 15
- 239000008194 pharmaceutical composition Substances 0.000 claims 15
- 238000000034 method Methods 0.000 claims 10
- 102000039446 nucleic acids Human genes 0.000 claims 9
- 108020004707 nucleic acids Proteins 0.000 claims 9
- 150000007523 nucleic acids Chemical class 0.000 claims 9
- 239000013612 plasmid Substances 0.000 claims 7
- 210000004027 cell Anatomy 0.000 claims 6
- IZFHEQBZOYJLPK-SSDOTTSWSA-N (R)-dihydrolipoic acid Chemical compound OC(=O)CCCC[C@@H](S)CCS IZFHEQBZOYJLPK-SSDOTTSWSA-N 0.000 claims 5
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 5
- 239000004480 active ingredient Substances 0.000 claims 5
- 229920001184 polypeptide Polymers 0.000 claims 5
- 102000004196 processed proteins & peptides Human genes 0.000 claims 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims 5
- 102000004169 proteins and genes Human genes 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 239000000654 additive Substances 0.000 claims 2
- 230000000996 additive effect Effects 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 230000003078 antioxidant effect Effects 0.000 claims 2
- 210000001723 extracellular space Anatomy 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 210000000056 organ Anatomy 0.000 claims 2
- 238000002360 preparation method Methods 0.000 claims 2
- 230000001105 regulatory effect Effects 0.000 claims 2
- 102000004127 Cytokines Human genes 0.000 claims 1
- 108090000695 Cytokines Proteins 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 claims 1
- 230000000844 anti-bacterial effect Effects 0.000 claims 1
- 230000000843 anti-fungal effect Effects 0.000 claims 1
- 230000001387 anti-histamine Effects 0.000 claims 1
- 230000000840 anti-viral effect Effects 0.000 claims 1
- 229940121375 antifungal agent Drugs 0.000 claims 1
- 239000000739 antihistaminic agent Substances 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 claims 1
- 238000004113 cell culture Methods 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 238000009792 diffusion process Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 239000005556 hormone Substances 0.000 claims 1
- 229940088597 hormone Drugs 0.000 claims 1
- 238000001802 infusion Methods 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 238000007911 parenteral administration Methods 0.000 claims 1
- 125000000864 peroxy group Chemical group O(O*)* 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 150000003384 small molecules Chemical class 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 claims 1
- 238000002054 transplantation Methods 0.000 claims 1
- 210000001215 vagina Anatomy 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2002129774/15A RU2280448C2 (ru) | 2002-11-10 | 2002-11-10 | Композиция с антиоксидантными свойствами и способ лечения болезней млекопитающих |
| RU2003123534/13A RU2250262C1 (ru) | 2003-07-29 | 2003-07-29 | РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pET23-a(+)PrxVIhumΔ178, КОДИРУЮЩАЯ N-КОНЦЕВОЙ ФРАГМЕНТ ПЕРОКСИРЕДОКСИНА VI ЧЕЛОВЕКА, И ШТАММ E.coli BL21/DE3/pET23-a(+)/PrxVIhumΔ178 - ПРОДУЦЕНТ N-КОНЦЕВОГО ФРАГМЕНТА ПЕРОКСИРЕДОКСИНА VI ЧЕЛОВЕКА |
| PCT/RU2003/000473 WO2004043485A1 (en) | 2002-11-10 | 2003-11-05 | Antioxidant pharmaceutical compound, method for producing polypeptide and method of cure |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006505290A JP2006505290A (ja) | 2006-02-16 |
| JP2006505290A5 true JP2006505290A5 (enExample) | 2006-12-21 |
Family
ID=32314175
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005506685A Pending JP2006505290A (ja) | 2002-11-10 | 2003-11-05 | 抗酸化医薬化合物、ポリペプチドの産生方法、治療方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8003345B2 (enExample) |
| EP (1) | EP1566182A4 (enExample) |
| JP (1) | JP2006505290A (enExample) |
| CA (1) | CA2505478A1 (enExample) |
| WO (1) | WO2004043485A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010101301A1 (en) * | 2009-03-05 | 2010-09-10 | National University Corporation University Of Fukui | Prophylaxis and treatment of macular degeneration and retinopathy using a prdx protein |
| EP3563862B1 (en) * | 2009-03-20 | 2021-05-05 | The General Hospital Corporation d/b/a Massachusetts General Hospital | D-arg-2'6'-dimethyltyrosine-lys-phe-nh2 for use in the prevention of secondary complications of burn injuries |
| EP2464739B1 (en) * | 2009-08-14 | 2016-01-13 | Basf Se | Methods in cell cultures, and related inventions, employing certain additives |
| US9181542B2 (en) * | 2010-10-25 | 2015-11-10 | Korea Atomic Energy Research Institute | Method for controlling the chaperone activity of peroxiredoxins using irradiation |
| CN102793911B (zh) * | 2011-05-24 | 2015-12-16 | 李建远 | 重组人Prx-6蛋白在治疗角膜损伤方面的用途 |
| CN102485272A (zh) * | 2010-12-06 | 2012-06-06 | 李建远 | 重组人Prx-6蛋白在治疗烧烫伤方面的用途 |
| WO2012075911A1 (zh) * | 2010-12-06 | 2012-06-14 | Li Jianyuan | 重组人prx-6蛋白在治疗烧烫伤和/或角膜损伤中的用途 |
| CN103417961B (zh) * | 2012-05-23 | 2018-02-09 | 烟台聚杰生物工程有限公司 | Prdx2和/或prdx6的新用途 |
| CN105211054B (zh) * | 2015-11-10 | 2017-05-24 | 刘娟 | 一种含重组人prdx4蛋白的人精液冷冻保护剂 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9612214D0 (en) | 1996-06-11 | 1996-08-14 | Mallinckrodt Veterinary Inc | Vaccine |
| CA2285631A1 (en) * | 1997-04-02 | 1998-10-08 | The Jackson Laboratory | Antioxidant protein 2, gene and methods of use therefor |
| BE1011331A6 (fr) * | 1997-08-20 | 1999-07-06 | Univ Catholique De Louvain Hal | Polypeptide associe au peroxysome, sequence nucleotidique encodant ledit polypeptide et leur utilisation dans le diagnostic et/ou le traitement de maladies ou de lesions pulmonaires. |
| AR042572A1 (es) * | 1999-04-02 | 2005-06-29 | Sod Conseils Rech Applic | Derivados de acido lipoico, procedimiento para su preparacion, medicamentos y composiciones farmaceuticas que los contienen y utilizacion de dichos derivados para la preparacion de los referidos medicamentos |
| FR2798672B1 (fr) | 1999-09-17 | 2003-10-31 | Commissariat Energie Atomique | Formes acides des peroxyredoxines et leur utilisation comme moyen de diagnostic |
| AU2001280199A1 (en) | 2000-08-28 | 2002-03-13 | Akira Awaya | Medicinal compositions |
| US20020168353A1 (en) | 2001-03-23 | 2002-11-14 | Lynn Ralf Geiben | Peroxiredoxin drugs for treatment of HIV-1 infection and methods of use thereof |
| WO2002061063A1 (en) * | 2001-01-30 | 2002-08-08 | Universite Catholique De Louvain | Crystal structure of peroxiredoxin 5 and its use for design of structural homologues |
| EP1394182A1 (en) | 2002-07-08 | 2004-03-03 | Europroteome AG | Agents and methods for diagnosis and therapy of cancer and cancer risk assessment |
| RU2280448C2 (ru) | 2002-11-10 | 2006-07-27 | Институт биофизики клетки РАН | Композиция с антиоксидантными свойствами и способ лечения болезней млекопитающих |
| RU2250262C1 (ru) | 2003-07-29 | 2005-04-20 | Институт биоорганической химии им. академиков М.М.Шемякина и Ю.А.Овчинникова РАН | РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pET23-a(+)PrxVIhumΔ178, КОДИРУЮЩАЯ N-КОНЦЕВОЙ ФРАГМЕНТ ПЕРОКСИРЕДОКСИНА VI ЧЕЛОВЕКА, И ШТАММ E.coli BL21/DE3/pET23-a(+)/PrxVIhumΔ178 - ПРОДУЦЕНТ N-КОНЦЕВОГО ФРАГМЕНТА ПЕРОКСИРЕДОКСИНА VI ЧЕЛОВЕКА |
| EP1664795B1 (en) | 2003-09-20 | 2017-11-08 | Electrophoretics Limited | Diagnostic method for brain damage-related disorders |
| KR100569165B1 (ko) | 2003-11-14 | 2006-04-07 | (주)아비코아생명공학연구소 | 닭 퍼옥시레독신 1 단백질 및 그를 코딩하는 핵산분자 |
| KR100605308B1 (ko) | 2003-12-01 | 2006-07-26 | 전남대학교산학협력단 | PrxⅡ 단백질의 혈관 내피세포 탐지용 마아커로서의 용도 |
| CA2567987A1 (en) | 2004-06-18 | 2005-12-29 | Gabriele Pestlin | Use of protein pdx1 as a marker for breast cancer |
| KR100953326B1 (ko) | 2004-08-31 | 2010-04-20 | 이화여자대학교 산학협력단 | 페록시레독신의 활성검출 키트 |
| KR100610774B1 (ko) | 2005-02-03 | 2006-08-28 | 이화여자대학교 산학협력단 | 퍼록시레독신 2 단백질을 유효성분으로 함유하는 혈관재협착 예방 및 치료용 약학조성물, 퍼록시레독신 2유전자 또는 그로부터 발현되는 단백질을 포함하는 혈관재협착 치료제 스크리닝용 조성물 및 이를 이용하는 혈관재협착 치료제 스크리닝 방법 |
| WO2007140976A2 (en) | 2006-06-06 | 2007-12-13 | F. Hoffmann-La Roche Ag | Enzymes as biomarker for alzheimer's disease |
| US20100297673A1 (en) | 2006-09-20 | 2010-11-25 | Reddy Us Therapeutics | Methods and compositions for upregulation of peroxiredoxin activity |
| JP2008275413A (ja) | 2007-04-27 | 2008-11-13 | Osaka Industrial Promotion Organization | 扁平上皮癌の診断用キット及び判定方法 |
-
2003
- 2003-11-05 US US10/534,238 patent/US8003345B2/en not_active Expired - Fee Related
- 2003-11-05 CA CA002505478A patent/CA2505478A1/en not_active Abandoned
- 2003-11-05 JP JP2005506685A patent/JP2006505290A/ja active Pending
- 2003-11-05 EP EP03774414A patent/EP1566182A4/en not_active Ceased
- 2003-11-05 WO PCT/RU2003/000473 patent/WO2004043485A1/ru not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Secombes et al. | Cytokines and innate immunity of fish | |
| Lefevre et al. | A novel and atypical type one interferon gene expressed by trophoblast during early pregnancy. | |
| RS63050B1 (sr) | Vakcine nukleinske kiseline | |
| WO2005055948A3 (en) | Epha2, epha4 and lmw-ptp and methods of treatment of hyperproliferative cell disorders | |
| KR20010006534A (ko) | Ⅱ형 tgf-베타 수용체/면역글로불린 불변 영역 융합 단백질 | |
| US8377883B2 (en) | Peptide for anti-angiogenesis and use thereof | |
| JP2006505290A5 (enExample) | ||
| CN101062952B (zh) | 由人血清白蛋白和干扰素组成的融合蛋白及其编码基因与应用 | |
| WO2004108088A3 (en) | Methods and compositions for interferon therapy | |
| JP5221959B2 (ja) | 代謝障害の状態を治療するためのil−22の使用 | |
| AU2010203446B2 (en) | Prevention and/or treatment of multiple organ dysfunction syndrome with interleukin-22 | |
| US10413586B2 (en) | Antiviral agent comprising recombinant mistletoe lectins | |
| SK287523B6 (sk) | Použitie CC chemokínového mutanta, farmaceutický prostriedok s obsahom chemokínového mutanta, skrátený a mutovaný humánny RANTES a spôsob jeho výroby | |
| CN111848780A (zh) | 一种IL-36的可溶性受体sIL-36R及其应用 | |
| ITRM950273A1 (it) | Antagonisti di interluchina-6 umana del tutto incapaci di formare un legame con gp 130, e loro uso per la preparazione di composizioni | |
| CN111777667B (zh) | 小肽及其在制备免疫调节药物中的应用 | |
| CN108690123B (zh) | 短肽在制备免疫调节药物中的应用 | |
| US20140038887A1 (en) | Glial cell line derived neurotrophic factor, obesity, and obesity-related diseases and conditions | |
| KR101466875B1 (ko) | 항종양괴사인자 수용체 2를 발현하도록 설계된 미니서클 벡터를 이용한 자가면역질환 치료 | |
| WO2002013845A3 (en) | Inflammation related g-protein coupled receptor | |
| WO2017101089A1 (zh) | 一种α促黑素细胞激素的融合蛋白及其制备方法和应用 | |
| US20180326009A1 (en) | Glial Cell Line Derived Neurotrophic Factor, Obesity, and Obesity-Related Diseases and Conditions | |
| CN117919385B (zh) | IL-37在MERS-CoV感染疾病的治疗中的应用 | |
| CN105017406B (zh) | 一类新的具有神经保护功能的多肽 | |
| CN113018424A (zh) | Cst1在预防和/或治疗肝脏免疫失调疾病中的应用 |